Light-activated antibodies could kill cancer cells

The idea, is a patient is injected with antibodies coated wih a light sensitive shell, then doctors shine ultraviolet light to activate the antibodies which attracts the T cells which attacks the tumour.

Safety trials could take another 10 years.